Back to previous section

Ondine appoints Alan Thomas as interim finance chief

Ondine Biomedical announced the appointment of Alan Thomas as its interim chief financial officer on Friday, with immediate effect, following the departure of Michael Behlke, who was stepping down from his role as CFO and chief operating officer for personal reasons.

  • Ondine Biomedical Inc. NPV (CDI)
  • 09 May 2025 12:50:30
Ondine Biomedical

Source: Sharecast

The AIM-traded company thanked Behlke for his service, and confirmed that his chief operating officer responsibilities would be absorbed by the existing executive team.

It said Thomas was bringing more than 25 years of financial leadership experience across the healthcare, biotechnology, and public infrastructure sectors, including senior roles at Maximus Canada, BC Transit, and BC Emergency Health Services.

He had also supported several high-growth firms through key strategic phases such as initial public offerings and investor relations.

Ondine said Thomas’s appointment came at a critical juncture, as it advanced the commercial expansion of its light-activated antimicrobial technology, with his expertise expected to enhance financial governance and strategic planning during the company’s next stage of growth.

“Ondine is entering an exciting phase of development, with growing momentum behind its breakthrough technology,” said Alan Thomas.

“I'm looking forward to working with the team to help drive the company's strategic and financial objectives forward.”

At 0802 BST, shares in Ondine Biomedical were down 3.89% at 8.65p.

Reporting by Josh White for Sharecast.com.

N/A

Isin: N/A
Exchange: N/A
Sell:
N/A
Buy:
N/A
Change:
Date:
Prices delayed by at least 15 minutes

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

View our accounts

Lloyds Bank is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.

Important legal information

Lloyds and Lloyds Bank are trading names of Halifax Share Dealing Limited. The Lloyds Bank Direct Investments Service is operated by Halifax Share Dealing Limited. Registered Office: Trinity Road, Halifax, West Yorkshire, HX1 2RG. Registered in England and Wales no. 3195646. Halifax Share Dealing Limited is authorised and regulated by the Financial Conduct Authority, 12 Endeavour Square, London, E20 1JN under registration number 183332. A Member of the London Stock Exchange and an HM Revenue & Customs Approved ISA Manager.

Logo Allfunds

The information contained within this website is provided by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd unless otherwise stated. The information is not intended to be advice or a recommendation to buy, sell or hold any of the shares, companies or investment vehicles mentioned, nor is it information meant to be a research recommendation. This is a solution powered by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd incorporating their prices, data news, charts, fundamentals and investor tools on this site. Terms and conditions apply. Prices and trades are provided by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd and are delayed by at least 15 minutes.

FE fundinfo Logo

Data provided by FE fundinfo. Care has been taken to ensure that the information is correct, but FE fundinfo neither warrants, represents nor guarantees the contents of information, nor does it accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. Past performance does not predict future performance, it should not be the main or sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise.

Refinitiv Logo

© 2025 Refinitiv, an LSEG business. All rights reserved.